Mankind Pharma Ltd. Conference Calls and Earnings Call Transcripts

09 Feb 2026

2292.90

2.59%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed herewith the transcript of the investor conference call for Q3 & 9M FY26 held on February 3, 2026.

03 Feb 2026

2292.90

2.59%

Mankind Pharma Results Earnings Call for Q3FY26

Conference Call with Mankind Pharma Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

11 Nov 2025

2292.90

2.59%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed herewith transcript of the investor Conference Call for Q2 & H1 FY 26

06 Nov 2025

2292.90

2.59%

Mankind Pharma Results Earnings Call for Q2FY26

Conference Call with Mankind Pharma Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.

06 Aug 2025

2292.90

2.59%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed herewith transcript of the Investor Conference Call for Q1 FY26 held on August 1, 2025

01 Aug 2025

2292.90

2.59%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Investor Conference Call for Q1 & FY26 - Audio Recording

01 Aug 2025

2292.90

2.59%

Mankind Pharma Results Earnings Call for Q1FY26

Conference Call with Mankind Pharma Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.

27 May 2025

2292.90

2.59%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Investor Conference Call for Q4 & FY25 - Transcript

21 May 2025

2292.90

2.59%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Investor Conference Call for Q4 & FY25 - Audio Recording

21 May 2025

2292.90

2.59%

Mankind Pharma Results Earnings Call for Q4FY25 & Full Year

Conference Call with Mankind Pharma Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.